Sertraline and Mirtazapine: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Mirtazapine
Sertraline
No brand names on record
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Both mirtazapine (Remeron) and sertraline (Zoloft) raise serotonin, a brain chemical that affects mood. When you take them together, the levels can add up. Most people do fine, but there is a small chance of a reaction called serotonin syndrome. Warning signs include shivering, muscle twitching or stiffness, a fast heartbeat, sweating, agitation, or feeling confused.
Both medicines can also, rarely, affect the heart's rhythm. Please don't stop either one on your own, because these drugs are often prescribed together on purpose. Your care team can watch for these signs and adjust things if needed. Call your doctor right away if you feel any of the symptoms above.
Additive serotonergic and QT effects. Both agents increase serotonergic tone (sertraline via SSRI reuptake inhibition; mirtazapine via alpha-2 and 5-HT modulation), raising serotonin syndrome risk. Both carry postmarketing QTc-prolongation signals, so combined use adds a theoretical risk of QT prolongation and torsades de pointes.
- Direction: additive pharmacodynamic effect (not a metabolic prodrug interaction).
- Onset: unspecified; highest risk at initiation and dose escalation.
- Evidence: theoretical/postmarketing.
- Management: monitor for serotonin syndrome (neuromuscular, autonomic, mental status changes); consider ECG/electrolyte review in patients with cardiac risk or other QT-prolonging drugs. Discontinue offending agents and give supportive care if syndrome develops.
What happens
Increased risk of serotonin syndrome, an increased risk of QT interval prolongation and an increased risk of torsades de pointes
Interaction Deep Dive
Exercise caution when mirtazapine is given together with other agents that prolong the QTc interval, because this combination raises the likelihood of QT prolongation and/or ventricular arrhythmias. Postmarketing experience has documented cases of QT prolongation, torsades de pointes, ventricular tachycardia, and sudden death associated with mirtazapine, with most of these events arising in the setting of overdose, existing cardiovascular disease or a family history of QT prolongation, or the simultaneous use of a QTc-prolonging drug. When mirtazapine is combined with other serotonergic agents, the additive serotonergic activity may heighten the risk of serotonin syndrome. Watch for signs of serotonin syndrome, particularly when starting therapy and when doses are raised, and should such symptoms appear, treat with mirtazapine and stop any concurrent serotonergic agent23. The manifestations of serotonin syndrome encompass neuromuscular abnormalities, autonomic hyperactivity, and alterations in mental status. This condition has the potential to be life-threatening. Should serotonin syndrome emerge once the causative agents have been stopped, deliver supportive care along with any other therapy that may be required1.
Why it happens (mechanism)
Additive serotonin effects; additive QT interval prolongation
How to manage this interaction
This combination is used intentionally in practice, so keep taking both exactly as prescribed unless your prescriber tells you otherwise.
- Watch especially in the first weeks and after any dose increase.
- Know the warning signs: tremor, muscle stiffness or twitching, fast heartbeat, sweating, agitation, confusion, or diarrhea. Seek care promptly if these appear.
- Your care team may monitor you more closely and, in people with heart rhythm risk factors, may check an ECG or electrolytes.
- Tell your pharmacist about all other medicines, since some add to these effects.
Doses can be tailored and individualized by your care team to keep you safe.
Management is individual — confirm any change with your pharmacist or prescriber.
Literature reports
3 reports — tap to read
a) A 75-year-old woman developed symptoms consistent with serotonin syndrome within a few hours of beginning mirtazapine and shortly after FLUoxetine was stopped. Her current medications for depression were FLUoxetine, chlorproMAZINE, and LORazepam. Because there was no response, FLUoxetine was stopped and mirtazapine 30 mg/day was begun soon after. Within a few hours of the mirtazapine, she developed dizziness, headache, nausea, dry mouth, and intense anxiety and agitation with suicidal ideas. Additional symptoms included difficulty walking, pronounced resting tremor of the hands, and insomnia. She grew progressively worse over the following 3 days. On day 5, mirtazapine was stopped. The next day her symptoms improved. On day 7, FLUoxetine 20 mg/day was resumed, after which the dizziness, nausea, headache, and agitation resolved over the following days. During the next 10 days, the tremor, anxiety, difficulty walking, dry mouth, and insomnia improved 4.
b) A 26-year-old woman with anorexia nervosa who had been receiving fluvoxaMINE for 4 months developed symptoms of serotonin syndrome after mirtazapine was started. The symptoms of twitching, tremors, agitation, restlessness, and "feeling like she could crawl out of her skin" appeared over a 4-day period after mirtazapine 30 mg/day was begun. The symptoms progressed quickly to twitching, tremors, and restlessness. She was hospitalized with additional symptoms of diaphoresis, flushing, fasciculations, and nausea and was treated with cyproheptadine, acetaminophen, and IV fluids. She stayed afebrile throughout the episode. The symptoms fully resolved within 24 hours 5.
c) Postmarketing reports involving mirtazapine have described QT prolongation, torsades de pointes, ventricular tachycardia, and sudden death, with most cases occurring in connection with overdose, known cardiovascular disease or a family history of QT prolongation, or the concurrent use of mirtazapine with QTc-prolonging agents 23.
Common questions
Can I take Sertraline and Mirtazapine together?
Taking mirtazapine and sertraline together adds up their serotonin and heart-rhythm effects, so keep taking both as prescribed but watch for symptoms like tremor, agitation, fast heartbeat, or confusion and report them to your care team right away. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Sertraline and Mirtazapine interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Sertraline and Mirtazapine interaction managed?
This combination is used intentionally in practice, so keep taking both exactly as prescribed unless your prescriber tells you otherwise. Watch especially in the first weeks and after any dose increase. Know the warning signs: tremor, muscle stiffness or twitching, fast heartbeat, sweating, agitation, confusion, or diarrhea. Seek care promptly if these appear. Your care team may monitor you more c… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
From our Q&A
Real reader questions about these medications, each personally answered by our pharmacist:
Questions for your pharmacist
- Does my dose of Sertraline or Mirtazapine need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (5)
- Boyer EW & Shannon M: The serotonin syndrome. N Eng J Med 2005; 352(11):1112-1120. PubMed
- Product Information: REMERON(R) oral tablets, mirtazapine oral tablets. Merck Sharp & Dohme Corp (per FDA), Whitehouse Station, NJ, 2020. DailyMed
- Product Information: Mirtazapine oral film coated tablets, mirtazapine oral film coated tablets. Apotex Corp (per DailyMed), Weston, FL, 2024. DailyMed
- Benazzi F: Serotonin syndrome with mirtazapine-fluoxetine combination. Int J Geriatr Psychiatry 1998; 13(7):495-496. DOI
- Demers JC & Malone M: Serotonin syndrome induced by fluvoxamine and mirtazapine. Ann Pharmacother 2001; 35:1217-1220. PubMed
Keep reading about Mirtazapine
Keep reading about Sertraline
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist